Acetic Acid

Acetic Acid

SCHEMBL727012

CC(=O)O.CC(=O)O.CC(=O)O.N.NCCO

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
TSHR P16473 2/20 0.53
FFAR3 O14843 2/20 0.47
LCK P06239 1/20 0.47
FYN P06241 1/20 0.47
GLRA1 P23415 1/20 0.39
SLC6A9 P48067 1/20 0.39
OR51E2 Q9H255 1/20 0.39
LMNA P02545 4/20 0.38
SLC15A2 Q16348 1/20 0.38
GABRR1 P24046 3/20 0.38
PAOX Q6QHF9 3/20 0.38
BLM P54132 3/20 0.36
THRB P10828 2/20 0.36
KMT2A Q03164 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
GABRR3 A8MPY1 1/20 0.36
GABRP O00591 1/20 0.36
GABRD O14764 1/20 0.36
HDAC3 O15379 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL3650850 1.00 ALDH1A1 (0.53) ALDH1A1TSHRFFAR3LCKFYN
Acetic Acid SCHEMBL503041 0.97
Acetic Acid SCHEMBL2140076 0.97 ALDH1A1 (0.57) ALDH1A1TSHRFFAR3LCKFYN
Acetic Acid SCHEMBL28674854 0.97 ALDH1A1 (0.57) ALDH1A1TSHRFFAR3LCKFYN
Acetic Acid SCHEMBL11054868 0.97 ALDH1A1 (0.57) ALDH1A1TSHRFFAR3LCKFYN
Acetic Acid SCHEMBL5819601 0.97 ALDH1A1 (0.57) ALDH1A1TSHRFFAR3LCKFYN
Acetic Acid SCHEMBL10983317 0.93
Acetic Acid SCHEMBL4530471 0.93 ALDH1A1 (0.53) ALDH1A1TSHRFFAR3LCKFYN
Acetic Acid SCHEMBL699745 0.93
Acetic Acid SCHEMBL6838880 0.93 ALDH1A1 (0.53) ALDH1A1TSHRFFAR3LCKFYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 287 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115028508-B Ethylene tetramerization process with reduced PE (polyethylene) production 万华化学集团股份有限公司 2023-05-26 CN claimed
CN-111132700-B Dual-mode radiotracer and therapeutic agent 慕尼黑工业大学 2022-12-13 CN claimed
CN-114686115-A Chemical mechanical polishing solution and use method thereof 安集微电子科技(上海)股份有限公司 2022-07-01 CN claimed
EP-1692145-B1 METHODS FOR PRODUCING COPPER ETHANOLAMINE SOLUTIONS ARCH CHEM INC (US) 2013-09-04 EP claimed
EP-2474328-A2 Mechanism-based targeted pancreatic beta cell imaging and therapy Board Of Regents, The University Of Texas System (US) 2012-07-11 EP claimed
US-20100278731-A1 Mechanism-Based Targeted Pancreatic Beta Cell Imaging and Therapy YANG DAVID J 2010-11-04 US claimed
CN-1867363-B Composition for imaging pancreas and use thereof UNIV TEXAS 2010-05-12 CN claimed
EP-1675625-A4 MECHANISM-BASED TARGETED PANCREATIC BETA CELL IMAGING AND THERAPY UNIV TEXAS (US) 2009-07-15 EP claimed
CN-101321542-A Microparticles for microarterial imaging and radiotherapy UNIV MARYLAND (US) 2008-12-10 CN claimed
CN-1867363-A Mechanism-based targeted pancreatic beta cell imaging and therapy UNIV TEXAS (US) 2006-11-22 CN claimed
EP-0752873-A4 LABELLED PEPTIDE COMPOUNDS MALLINCKRODT INC (US) 2002-05-15 EP claimed
US-6312661-B1 DETECTION OF TUMORS, RADIOACTIVE ISOTOPES, AGONIST OR ANTAGONIST, METALS AND HALOGENS MALLINCKRODT INC. 2001-11-06 US claimed
US-6194386-B1 SELECTIVE AFFINITY TO NEUROTENSIN RECEPTORS, COMPARABLE WITH THAT OF NEUROTENSIN ITSELF, AND WHICH HAS SUFFICIENT ENZYMATIC RESISTANCE TO ALLOW ITS USE IN DIAGNOSIS AND THERAPY; RADIOACTIVE CHELATE PEPTIDES; IN VIVO STABILITY MALLINCKRODT INC. 2001-02-27 US claimed
US-5952464-A OLIGOPEPTIDE WITH SELECTIVE NEUROTENSIN RECEPTOR AFFINITY LABELLED WITH METAL ISOTOPE OR RADIOACTIVE HALOGEN ISOTOPE; FOR DIAGNOSTIC IMAGING AND ANTICARCINOGENIC AGENTS MALLINCKRODT INC. (US) 1999-09-14 US claimed
EP-0885017-A2 USE OF LABELLED CCK-B RECEPTOR LIGANDS FOR THE DETECTION AND LOCALIZATION OF MALIGNANT HUMAN TUMOURS MALLINCKRODT MEDICAL, INC. (US) 1998-12-23 EP claimed
WO-1997031657-A2 USE OF LABELLED CCK-B RECEPTOR LIGANDS FOR THE DETECTION AND LOCALIZATION OF MALIGNANT HUMAN TUMORS MALLINCKRODT MEDICAL, INC. (US) 1997-09-04 WO claimed
EP-0752873-A1 LABELLED PEPTIDE COMPOUNDS MALLINCKRODT MEDICAL, INC. (US) 1997-01-15 EP claimed
WO-1996023527-A1 METHOD FOR THE DETECTION AND LOCALIZATION OF MALIGNANT HUMAN TUMOURS MALLINCKRODT MEDICAL, INC. (US) 1996-08-08 WO claimed
WO-1995022341-A1 LABELLED PEPTIDE COMPOUNDS MALLINCKRODT MEDICAL, INC. (US) 1995-08-24 WO claimed
US-5128046-A Chelation, coagulation, water pollution control NALCO CHEMICAL COMPANY (US) 1992-07-07 US claimed